Edmond Sara N, Turk Dennis C, Williams David A, Kerns Robert D
Pain Research, Informatics, Multimorbidities, and Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, CT, USA.
Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Pain Rep. 2018 May 23;4(3):e655. doi: 10.1097/PR9.0000000000000655. eCollection 2019 May-Jun.
A growing number and type of nonpharmacological approaches for the management of chronic pain have demonstrated at least modest evidence of efficacy, and for some, there is emerging evidence of their effectiveness in relatively large scale trials. Behavioral approaches are those that generally seek to promote adaptive behavioral change in the service of reducing pain and improving physical and emotional functioning and quality of life. Despite a substantial empirical literature supporting the clinical utility of these approaches, a large number of unanswered questions remain and clinical trials to answer some of these questions are needed. Although considerations for development and enactment of data-analytic plans are generally similar to those in pharmacological trials (eg, intent-to-treat, prespecifying outcomes and time points, and handling of missing data), there may be some important differences to consider when planning and conducting clinical trials examining these behavioral approaches.
The primary objective of this article is to describe some aspects of clinical trials for behavioral approaches for the management of chronic pain that requires special consideration.
Important topics discussed include: (1) intervention development, (2) research design considerations (adequate and appropriate control and comparison conditions), (3) appropriate outcomes, (4) recruitment and sampling biases and blinding, (5) intervention fidelity and adherence, and (6) demographic and cultural considerations.
A number of methodological recommendations are made in the service of encouraging the conduct of high-quality research comparable with that performed for pharmacological and other medical interventions.
越来越多类型的慢性疼痛非药物治疗方法已显示出至少适度的疗效证据,对于其中一些方法,在相对大规模试验中也出现了其有效性的证据。行为疗法通常旨在促进适应性行为改变,以减轻疼痛、改善身体和情绪功能以及生活质量。尽管有大量实证文献支持这些方法的临床效用,但仍有许多未解决的问题,需要进行临床试验来回答其中一些问题。虽然制定和实施数据分析计划的考虑因素通常与药物试验中的类似(例如,意向性分析、预先确定结局和时间点以及处理缺失数据),但在规划和开展检验这些行为疗法的临床试验时,可能需要考虑一些重要差异。
本文的主要目的是描述慢性疼痛行为疗法临床试验中需要特别考虑的一些方面。
讨论的重要主题包括:(1)干预措施的开发,(2)研究设计考量(充分且合适的对照和比较条件),(3)恰当的结局指标,(4)招募和抽样偏差以及盲法,(5)干预的保真度和依从性,以及(6)人口统计学和文化方面的考量。
为鼓励开展与药物及其他医学干预研究质量相当的高质量研究,提出了一些方法学建议。